REFERENCES
- Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52:1527–1539.
- Huffman C, Wagman G, Fudim M, Reversible cardiomyopathies—a review. Transplant Proc. 2010;42:3673–3678.
- Töz H, Ozkahya M, Ozerkan F, Improvement in “uremic” cardiomyopathy by persistent ultrafiltration. Hemodial Int. 2007;11:46–50.
- Hung J, Harris PJ, Uren RF, Uremic cardiomyopathy: effect of hemodialysis on left ventricular function in end stage renal failure. N Engl J Med. 1980;302:547–551.
- Golf S, Lunde P, Abrahamsen AM, Effect of hydration state on cardiac function in patients on chronic hemodialysis. Br Heart J. 1983;49:183–186.
- Evrenkaya TR, Cingözbay BY, Altıntaş S, The effects of ultrafiltration on digitalis like immunoreactive substance (DLIS), atrial natriuretic peptide (ANP) and echocardiography parameters. Turk Neph Dial Transpl. 2002;11:8–14.
- Vanholder R, Massy Z, Argiles A, Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant. 2005;20:1048–1056.
- Parfrey PS, Griffiths SM, Harnett JD, Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease, and ischemic heart disease in dialysis patients. Am J Nephrol. 1980;10:213–221.
- Foley RN, Parfrey PS, Harnett JD, Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47:186–192.
- Drüeke T, Le Pailleur C, Meilhac B, Congestive cardiomyopathy in uraemic patients on long term hemodialysis. Br Med J. 1997;1:350–353.
- Parfrey PS, Harnett JD, Barre PE. The natural history of myocardial disease in dialysis patients. J Am Soc Nephrol. 1991;2:2–12.
- Boran M, Kural T, Koramaz Ş, Evaluation of left ventricular function in hemodialysis patients after renal transplantation. Turk Neph Dial Transpl. 1995;2:115–118.
- Töz H, Ozerkan F, Unsal A, Dilated uremic cardiomyopathy in a dialysis patient cured by persistent ultrafiltration. Am J Kidney Dis. 1998;32:664–668.
- Ozkahya M, Ok E, Cirit M, Regression of left ventricular hypertrophy in hemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant. 1998;13:1489–1493.
- Cirit M, Ozkahya M, Cinar CS, Disappearance of mitral and tricuspid regurgitation in hemodialysis patients after ultrafiltration. Nephrol Dial Transplant. 1998;13:389–392.
- Koçyiğit İ, Ünal A, Çelik A, Effects of renal transplantation on cardiac function and morphology in the late posttransplant period. Turk Neph Dial Transpl. 2012;21:28–33.
- Zolty R, Hynes PJ, Vittorio TJ. Severe left ventricular systolic dysfunction may reverse with renal transplantation: uremic cardiomyopathy and cardiorenal syndrome. Am J Transplant. 2008;8:2219–2224.
- Parfrey PS, Harnett JD, Foley RN, Impact of renal transplantation on uremic cardiomyopathy. Transplantation. 1995;60:908–914.